Literature DB >> 22574663

Prevalence and early detection of abdominal aortic aneurysm in pseudoexfoliation syndrome and pseudoexfoliation glaucoma.

Jasmina Djordjevic-Jocic1, Predrag Jovanovic, Marija Bozic, Aleksandar Tasic, Zoran Rancic.   

Abstract

PURPOSE: The goals of this study were to demonstrate the frequency of infrarenal abdominal aortic aneurysm (AAA) in patients with pseudoexfoliation (PEX) syndrome (PEXS) and PEX glaucoma (PEXG), and to determine whether limited screening for AAA in specific subgroups of patients with PEX is reasonable and justifiable.
MATERIALS AND METHODS: This prospective study comprised 60 patients with PEXS and 60 with PEXG (examined group), and 60 patients with primary open-angle glaucoma (POAG) and 60 with cataract (control group). Clinical ophthalmic examination included slit-lamp biomicroscopy of the anterior segment and direct slit-lamp gonioscopy (using a Goldmann three-mirror lens) of the anterior chamber angle. All patients underwent routine Color Doppler duplex ultrasonography of the infrarenal aorta and iliac arteries.
RESULTS: There was a statistically significant difference (p < 0.05) between the PEXG group and control group vis-a-vis presence of AAA, which occurred more frequently in patients with greater amounts of angle pigmentation (p < 0.05). Univariate logistic regression analysis indicated statistically significant associations between AAA and PEX (p < 0.01), angle pigmentation (p < 0.05), gender (p < 0.01), diabetes mellitus (DM) (p < 0.05), and arterial hypertension (AHT) (p < 0.01). Multivariate regression analysis, adjusted to gender and age, showed that the most important clinical parameters related to AAA in patients with PEXS and PEXG are gender, presence of PEX, DM, and AHT (p < 0.05).
CONCLUSION: The frequency of AAA is significantly higher in patients with PEXS and PEXG than in patients with POAG or cataract. Restricted screening for AAA in male PEXS patients, who also have elevated degrees of angle pigmentation, arterial hypertension, and DM, is clinically warranted.

Entities:  

Mesh:

Year:  2012        PMID: 22574663     DOI: 10.3109/02713683.2012.665120

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  15 in total

1.  Electroneuromyographic findings in pseudoexfoliation syndrome.

Authors:  Deniz Turgut Coban; Tuncay Cakir; Muhammet Kazim Erol; Gulsum Dogan; Berna Dogan; Meral Bilgilisoy Filiz; Naciye Fusun Toraman
Journal:  Int Ophthalmol       Date:  2017-04-12       Impact factor: 2.031

2.  Pseudoexfoliation syndrome: analysis of systemic comorbidities of 325 PEX-positive patients compared with 911 PEX-negative patients.

Authors:  Elizabeth Scharfenberg; Franziska G Rauscher; Petra Meier; Dirk Hasenclever
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-16       Impact factor: 3.117

Review 3.  Genomic and proteomic pathophysiology of pseudoexfoliation glaucoma.

Authors:  Luis E Vazquez; Richard K Lee
Journal:  Int Ophthalmol Clin       Date:  2014

4.  Association of Exfoliation Syndrome With Risk of Indirect Inguinal Hernia: The Utah Project on Exfoliation Syndrome.

Authors:  Brian M Besch; Karen Curtin; Robert Ritch; R Rand Allingham; Barbara M Wirostko
Journal:  JAMA Ophthalmol       Date:  2018-12-01       Impact factor: 7.389

5.  Renal artery stenosis and abdominal aorta aneurysm in patients with pseudoexfoliation syndrome.

Authors:  K A Gonen; T Gonen; B Gumus
Journal:  Eye (Lond)       Date:  2013-04-12       Impact factor: 3.775

Review 6.  Pseudoexfoliation syndrome and cardiovascular diseases.

Authors:  Georgios K Andrikopoulos; Dimitrios K Alexopoulos; Sotirios P Gartaganis
Journal:  World J Cardiol       Date:  2014-08-26

Review 7.  A Case-Cohort Study of Exfoliation Risk Factors and Literature Review.

Authors:  Ahmad M Mansour; Anastasios G P Konstas; Hana A Mansour; Abdul R Charbaji; Khalil M El Jawhari
Journal:  Middle East Afr J Ophthalmol       Date:  2021-04-30

8.  Ocular pseudoexfoliation syndrome and life span.

Authors:  Jon Klokk Slettedal; Leiv Sandvik; Amund Ringvold
Journal:  EBioMedicine       Date:  2015-05-30       Impact factor: 8.143

Review 9.  Cardiovascular repercussions of the pseudoexfoliation syndrome.

Authors:  Vasiliki Katsi; Antonios N Pavlidis; Manolis S Kallistratos; Athanasios Fitsios; Athanasios Bratsas; Dimitris Tousoulis; Christodoulos Stefanadis; Athanasios J Manolis; Ioannis Kallikazaros
Journal:  N Am J Med Sci       Date:  2013-08

Review 10.  Ocular pseudoexfoliation syndrome and vascular disease: a systematic review and meta-analysis.

Authors:  Wei Wang; Miao He; Minwen Zhou; Xiulan Zhang
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.